Regal Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-18,699
| Closed | -$2.27M | – | 280 |
|
|
2017
Q1 | $2.27M | Sell |
18,699
-2,810
| -13% | -$341K | 0.59% | 60 |
|
|
2016
Q4 | $2.63M | Sell |
21,509
-714
| -3% | -$87.4K | 0.73% | 51 |
|
|
2016
Q3 | $2.72M | Sell |
22,223
-1,452
| -6% | -$178K | 0.77% | 47 |
|
|
2016
Q2 | $2.76M | Buy |
+23,675
| New | +$2.76M | 0.76% | 51 |
|
|
2015
Q4 | – | Sell |
-210
| Closed | -$32K | – | 948 |
|
|
2015
Q3 | $32K | Buy |
210
+10
| +5% | +$1.52K | 0.01% | 483 |
|
|
2015
Q2 | $36K | Hold |
200
| – | – | 0.01% | 475 |
|
|
2015
Q1 | $35K | Hold |
200
| – | – | 0.01% | 482 |
|
|
2014
Q4 | $37K | Hold |
200
| – | – | 0.01% | 440 |
|
|
2014
Q3 | $33K | Hold |
200
| – | – | 0.01% | 477 |
|
|
2014
Q2 | $31K | Hold |
200
| – | – | 0.01% | 474 |
|
|
2014
Q1 | $30K | Hold |
200
| – | – | 0.01% | 438 |
|
|
2013
Q4 | $27K | Hold |
200
| – | – | 0.02% | 396 |
|
|
2013
Q3 | $23K | Hold |
200
| – | – | 0.01% | 449 |
|
|
2013
Q2 | $18K | Buy |
+200
| New | +$18K | 0.01% | 482 |
|